Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × eribulin × Clear all

Sponsor

Conditions

Breast Neoplasms 40 Neoplasms 12 Neoplasm Metastasis 8 Sarcoma 6 Triple Negative Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Liposarcoma 2 Leiomyosarcoma 2 Inflammatory Breast Neoplasms 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasm, Residual 1 Metastatic Urothelial Cell Cancer 1 Lymphoma 1 Lung Neoplasms 1 Ketosis 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1

Interventions

Bevacizumab 101 Fluorouracil 88 Leucovorin 86 Oxaliplatin 85 Irinotecan 76 Capecitabine 65 Cetuximab 54 Panitumumab 35 pembrolizumab 33 regorafenib 25 Nivolumab 22 Folfox protocol 19 IFL protocol 17 trifluridine tipiracil drug combination 11 durvalumab 11 Radiotherapy 11 Gemcitabine 8 tremelimumab 7 aflibercept 7 Cyclophosphamide 7 Celecoxib 7 binimetinib 6 Sunitinib 6 Drug Therapy 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6 cediranib 5 Trifluridine 5 Surgical Procedures, Operative 5 Immunoglobulin G 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡